ImmunityBio reports $113 million revenue, 700% annual increase

Go back to ImmunityBio reports $113 million revenue, 700% annual increase
(NASDAQ: IBRX) Delayed: 7.25 +0.30 (4.32%)
Previous Close $6.95    52 Week High
Open $6.96    52 Week Low
Day High $7.41    P/E N/A 
Day Low $6.94    EPS
Volume 11,496,600